Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (221-230 of 423) with videos related to

Pageof 43
Sort By:
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Journal of Hepatology|September 20, 2020
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental modelsPui Y Lee-Law, Paula Olaizola, Francisco J Caballero-Camino, et al.
United European Gastroenterology Journal|December 3, 2014
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screeningJoaquín Cubiella, Inés Castro, Vicent Hernandez, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
United European Gastroenterology Journal|June 9, 2018
Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradoxCarolina Mangas-Sanjuan, Pedro Zapater, Joaquín Cubiella, et al.
Endoscopy|February 5, 2016
Endoscopist characteristics that influence the quality of colonoscopyRodrigo Jover, Pedro Zapater, Luis Bujanda, et al.
World Journal of Gastroenterology|January 15, 2020
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical testNoel Pin-Vieito, María J Iglesias, David Remedios, et al.
Pageof 43

Showing results (221-230 of 423) with videos related to

Sort By:
Pageof 43
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
Journal of Hepatology|September 20, 2020
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental modelsPui Y Lee-Law, Paula Olaizola, Francisco J Caballero-Camino, et al.
United European Gastroenterology Journal|December 3, 2014
Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screeningJoaquín Cubiella, Inés Castro, Vicent Hernandez, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
United European Gastroenterology Journal|June 9, 2018
Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradoxCarolina Mangas-Sanjuan, Pedro Zapater, Joaquín Cubiella, et al.
Endoscopy|February 5, 2016
Endoscopist characteristics that influence the quality of colonoscopyRodrigo Jover, Pedro Zapater, Luis Bujanda, et al.
World Journal of Gastroenterology|January 15, 2020
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical testNoel Pin-Vieito, María J Iglesias, David Remedios, et al.
Pageof 43